Wednesday, July 8, 2026

pharma · Acute Schizophrenia · Schizophrenia · RVPH

REVIVA PHARMACEUTICALS HOLDINGS

REVIVA PHARMACEUTICALS HOLDINGS drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Cupertino, USA HQ
20 Employees
Public company Type
RVPH · NYSE Ticker
Company details
Status
Public
HQ
Cupertino, USA
Employees
20
Programs
3
Drugs
1
Patents
28
Intelligence · Drug Pipeline

REVIVA PHARMACEUTICALS HOLDINGS pipeline

Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

REVIVA PHARMACEUTICALS HOLDINGS drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

1 compounds
  1. Development asset linked to REVIVA PHARMACEUTICALS HOLDINGS in public FDA and regional records.